Document is current
Any future updates will be listed below
-
Authors
Gonzalez-Lozano, Miguel A. https://orcid.org/0000-0002-7837-151X
Schmid, Ernst W. https://orcid.org/0000-0002-4662-5298
Miguel Whelan, Enya https://orcid.org/0000-0003-1525-7207
Jiang, Yizhi https://orcid.org/0000-0001-9016-1104
Paulo, Joao A. https://orcid.org/0000-0002-4291-413X
Walter, Johannes C. https://orcid.org/0000-0002-4186-7570
Harper, J. Wade https://orcid.org/0000-0002-6944-7236
- License Information
-
More Information
Article History
Received: 18 August 2024
Accepted: 23 April 2025
First Online: 28 May 2025
Competing interests
: J.W.H. is a co-founder of Caraway Therapeutics (a subsidiary of Merck, Inc.) and is a scientific advisory board member for Lyterian Therapeutics. All other authors declare no competing interests.
